Navigation Links
Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
Date:2/25/2009

SOUTH SAN FRANCISCO, Calif., Feb. 25 /PRNewswire/ -- Proteolix, Inc., a leader in the discovery and development of novel therapeutics that target protein degradation pathways in cancer and autoimmune diseases, today announced the appointment of John A. Scarlett, M.D., to the position of President and Chief Executive Officer. Dr. Scarlett brings nearly 30 years of experience in drug development and commercialization to his new role. Susan Molineaux, Ph.D., who founded Proteolix in 2003, will transition from her position as Chief Executive Officer to serve as the company's Chief Scientific Officer.

"I am pleased to join the outstanding team at Proteolix, whose efforts have resulted in the discovery of the company's lead anticancer product, the proteasome inhibitor carfilzomib, for the treatment of multiple myeloma and other cancers," said Dr. Scarlett. "In particular, I am excited by the opportunity to oversee the advancement of carfilzomib, which has shown compelling single agent activity in several Phase 2 trials in multiple myeloma, through the final stages of clinical testing and into commercialization."

"I welcome Dr. Scarlett, whose extensive clinical and commercial experience will serve as an important asset to the company as carfilzomib advances through late-stage trials," stated Dr. Molineaux. "Proteolix has been successful in discovering and developing several inhibitors that selectively target the proteasome in new ways, which has allowed us to develop effective therapies for the treatment of both cancer and autoimmune diseases. I am proud of the progress our team has achieved to date and look forward to our continued successes."

On behalf of the Company's Board of Directors, Chairman Paul Hastings commented, "Proteolix has made remarkable strides under the leadership of Susan Molineaux in taking carfilzomib all the way from discovery through to successful Phase 2 clinical trials in a short pe
'/>"/>

SOURCE Proteolix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Proteolix Announces Clinical Results With Carfilzomib to be Reported at ASH 2007 Annual Meeting
2. Proteolix Names Matthew Ferguson to Newly-Created Position of Chief Financial Officer
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... in virus , , SUNDAY, Dec. 6 (HealthDay News) -- Early ... in a tiger that lived thousands or millions of years ... took on a bit of a tiger,s genetic material, scientists ... virus to this day. That tiger, in fact, may have ... that ultimately led to its infection of humans. , The ...
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Blood clotting, ... excessive bleeding when a blood vessel is injured. ... vessels without an obvious injury or do not ... Research presented today at the 51st Annual Meeting ... the practice of using the anticoagulants aspirin and ...
(Date:12/6/2009)... of Belluck & Fox, LLP says dangerous substances such as asbestos ... ... New York, NY (PRWEB) December 6, 2009 -- As ... be alert to reports of recalls due to lead paint or ... to 230,000 children visit hospital emergency rooms each year due to ...
(Date:12/5/2009)... South Africa, December 5 The first Football,for ... Cape Town opened its doors,today (5 December 2009). ... Cape Premier Helen Zille, 2010 FIFA World Cup ... African Football Association,President Kirsten Nematandani and Executive Mayor ...
(Date:12/5/2009)... debunks the ,something,s wrong with being single, myth , , SATURDAY, ... who pass their 40th birthday without ever tying the knot, ... woes than married folks. And, um, isn,t there something wrong ... fast. , A new study looking at psychological measures shows ...
Breaking Medicine News(10 mins):Health News:AIDS May Date Back to Ancient Tiger 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3
... ZINO Society is pleased to present ZINO,Life: ... Washington,Biotechnology and Biomedical Association (WBBA), on February 24, ... ZINO Life will include exhibition space, networking, company,presentations, ... panel including H. Stewart Parker (formerly Targeted Genetics), ...
... candidate as marker for metastasis , , MONDAY, Dec. 8 ... the spread of breast cancer has been identified by ... in invasive cells within a breast tumor. The protein ... cancer, the scientists said. , These invasive cells move ...
... PHILADELPHIA and SAN FRANCISCO, Dec. 8 Screening ... in preventing stroke among children with sickle cell ... treated with blood transfusions. Over an eight-year period ... that the technique, transcranial Doppler ultrasonography (TCD), along ...
... 8 In a lawsuit arising out of the ... organization,servicing primarily Medicaid recipients, several major Detroit area hospitals,filed ... Court against,United American Healthcare Corporation, the former manager of ... In the emergency motion, the hospitals -- Beaumont ...
... of Warwick have discovered high doses of thiamine vitamin ... disease. , Kidney disease, or diabetic nephropathy, develops progressively in ... is assessed by a high excretion rate of the protein ... , The research is led by Dr Naila Rabbani and ...
... Holdings, Inc., today,announced the appointment of Diane H. Partridge ... acute care hospital system. She will report to,Phillip B. ... A proven sales and marketing leader, Partridge ... experience in senior,marketing, business development and operational roles at ...
Other Medicine News:Health News:ZINO Society's Call for Life Sciences Entrepreneurs Seeking Funding 2Health News:Scientists ID Protein Aiding Breast Cancer Spread 2Health News:Ultrasound Screening Helps Prevent Stroke in Children With Sickle Cell Disease 2Health News:Ultrasound Screening Helps Prevent Stroke in Children With Sickle Cell Disease 3Health News:Detroit Area Hospitals Sue To Recover Medicaid Funds 2Health News:Vitamin B1 could reverse early-stage kidney disease in diabetes patients 2
(Date:12/4/2009)... Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: ... confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an ... and Drug Administration seeking approval to market its 8mg ... owned by Takeda Pharmaceutical Company Limited. Watson,s 8mg ...
(Date:12/4/2009)... WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: ... Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine ... antidepressants in adults with Major Depressive Disorder (MDD). SEROQUEL ... by the FDA to treat both major depressive disorder ...
(Date:12/3/2009)... Pa., Dec. 3 Ambry Genetics and SoftGenetics ... provide extended bioinformatics genomics services using SoftGenetics, NextGENe ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20090428/LA06744LOGO ) ... team at Ambry has been providing genomics solutions ...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3PROLOR Biotech Acquires License Option from Yeda for Development of Long Acting Anti Obesity Drug 13205 1PROLOR Biotech Acquires License Option from Yeda for Development of Long Acting Anti Obesity Drug 13205 2PROLOR Biotech Acquires License Option from Yeda for Development of Long Acting Anti Obesity Drug 13205 3Premier Visiting Nurse Selects Cardiocom Telehealth Technology 52752 1Premier Visiting Nurse Selects Cardiocom Telehealth Technology 52752 2Booth Radiology Extends and Elevates Partnership With AMICAS 52747 1Booth Radiology Extends and Elevates Partnership With AMICAS 52747 2Booth Radiology Extends and Elevates Partnership With AMICAS 52747 3
... BROOK, N.Y., Oct. 4 Stony Brook based ... developer of 3D,imaging software announced today the publication ... of Medicine, titled "CT Colonography versus Colonoscopy for,the ... Viatronix V3D-,Colon platform exclusively. The results published ...
... Pa., Oct. 3 ViroPharma Incorporated,(Nasdaq: VPHM ... and chief,executive officer of ViroPharma, will present at ... Monday, October 8, 2007. The conference is,being held ... ViroPharma,s presentation will be webcast live for investors ...
Other Medicine Technology:Viatronix V3D-Colon Utilized in 'Another' Landmark Study 2
... 755 simplifies and automates high-volume ... automation and advanced technologies into ... accurate results every time. Plus, ... quality with its slide-on-slide smearing ...
... from the ground-up with ergonomic concerns in ... most adjustable observation tube on the market. ... user can adjust the microscope to suit ... the operator maintain an upright, comfortable posture, ...
... The Coolscope operates with a ... a monitor display. Direct the mouse ... the macro image of the slide ... instantly. The intuitive Graphic User Interface ...
... laboratory microscope whose superior ergonomics, ... to make it the ideal ... designed to fit the user ... to fit the microscope. Optimized ...
Medicine Products: